Cutaneous Lichen Planus
3 clinical trials · Condition
◉ Watch Cutaneous Lichen Planus
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus (NCT07775924) | Novartis Pharmaceuticals | 2026-09-10 |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus (NCT05593432) | Incyte Corporation | 2022-11-23 |
| Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus (NCT05188521) | Aaron R. Mangold | 2022-01-11 |
Track Cutaneous Lichen Planus automatically
Every clearance here is in the API, with alerts when new ones post.